Search by Drug Name or NDC

    NDC 63304-0192-90 Desvenlafaxine 100 mg/1 Details

    Desvenlafaxine 100 mg/1

    Desvenlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is DESVENLAFAXINE.

    Product Information

    NDC 63304-0192
    Product ID 63304-192_cd04a0b2-a7f2-4629-997f-af2a8e65f15b
    Associated GPIs 58180020007540
    GCN Sequence Number 070830
    GCN Sequence Number Description desvenlafaxine TAB ER 24H 100 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 34482
    HICL Sequence Number 040202
    HICL Sequence Number Description DESVENLAFAXINE
    Brand/Generic Generic
    Proprietary Name Desvenlafaxine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Desvenlafaxine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name DESVENLAFAXINE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204150
    Listing Certified Through 2024-12-31

    Package

    NDC 63304-0192-90 (63304019290)

    NDC Package Code 63304-192-90
    Billing NDC 63304019290
    Package 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-192-90)
    Marketing Start Date 2013-03-05
    NDC Exclude Flag N
    Pricing Information N/A